Dietary supplement use is often not reported to health care teams
the ONA take:
Research from Boston Medical Center found that some clinicians are not asking patients about their dietary supplement use, some patients do not disclose their use of them, and dietary supplement use is often not included in medical documentation.
This can challenge the effectiveness of prescription regimens and lead to serious repercussions for patients.
Researchers recently found an amphetamine-like stimulant in dietary supplements. As a result, stores such as the Vitamin Shoppe pulled as many as 25 supplements off their shelves because they contained the ingredient, which was linked to a woman’s stroke.
Another recent study found a number of supplements may even increase the risk of developing certain cancers.
Patients may not know that their health care team needs this information when planning their care or fear being judged for their use of the products.
The researchers conclude that clinicians need to be more conscious of and better educated on the importance of talking with patients of all ages and cultural backgrounds about dietary supplement use.
Some patients do not disclose their use of them, and dietary supplement use is often not included in medical documentation.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|